MGP
FOLD

M&G plc’s Amicus Therapeutics FOLD Stock Holding History

M&G plc’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,884,985
Closed -$11.3M – 408
2025
Q2 		$11.3M Buy
+1,884,985
New +$12.2M 0.06% 184
2024
Q3 		– Sell
-748,451
Closed -$7.48M – 421
2024
Q2 		$7.48M Buy
748,451
+82,728
+12% +$849K 0.03% 242
2024
Q1 		$7.99M Buy
+665,723
New +$8.51M 0.03% 245

Other funds holding FOLD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

M&G plc's FOLD Position: Q3 2025 in Review

M&G plc sold out of Amicus Therapeutics (FOLD) in Q3 2025, closing a stake of 1,884,985 shares — an estimated $11.3M sold.

M&G plc first reported a position in FOLD in Q1 2024 and held it in 3 quarters. The position peaked at $11.3M in Q2 2025. 287 funds tracked by Wall St. Rank hold FOLD as of Q3 2025.

  • M&G plc reported no remaining Amicus Therapeutics position as of Q3 2025 after selling out during the quarter.
  • M&G plc sold 1,884,985 Amicus Therapeutics shares in Q3 2025, an estimated $11.3M.
  • M&G plc first reported a position in Amicus Therapeutics in Q1 2024 and held it in 3 quarters.
  • M&G plc's Amicus Therapeutics position peaked at $11.3M in Q2 2025.
  • 287 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q3 2025.

Based on M&G plc's 13F filing for Q3 2025, filed 7 Nov 2025.